BioTech News and Headlines

Epigenome Study Links DNA Methylation to Cancer Survivors’ Heart Risk
NewsJan 24, 2026

Epigenome Study Links DNA Methylation to Cancer Survivors’ Heart Risk

A new epigenome-wide association study has identified distinct DNA‑methylation patterns that correlate with heightened cardiovascular risk among cancer survivors. Researchers examined over 5,000 individuals who had completed chemotherapy or radiation, pinpointing several CpG sites linked to arterial inflammation and plaque...

By Bioengineer.org
Morning Serum Cortisol: Key to Adrenal Insufficiency Diagnosis
NewsJan 24, 2026

Morning Serum Cortisol: Key to Adrenal Insufficiency Diagnosis

A recent clinical guideline underscores morning serum cortisol as the primary screening tool for adrenal insufficiency, recommending a threshold of 3 µg/dL to rule out disease and 15 µg/dL to confirm diagnosis. The guideline highlights that a single early‑morning draw,...

By Bioengineer.org
Rats Can Differentiate Between Two White Wine Varieties
NewsJan 24, 2026

Rats Can Differentiate Between Two White Wine Varieties

Researchers led by Enrico Frasnelli demonstrated that rats can reliably differentiate between two white‑wine varieties—one Italian and one French—and even generalize their preferences across the pair. The study employed controlled olfactory‑taste trials with positive reinforcement, revealing consistent choice patterns that...

By Bioengineer.org
Link Between Osteosarcopenia and Frailty in Seniors
NewsJan 24, 2026

Link Between Osteosarcopenia and Frailty in Seniors

A new study links osteosarcopenia—a combination of low bone mineral density and reduced muscle mass—to heightened frailty in seniors. Researchers integrated BMD measurements, FRAX® scores, and femoral strength assessments to create a composite risk model. The analysis revealed that seniors...

By Bioengineer.org
NK Cell Infusion Shows Promise in Liver Cancer Trial
NewsJan 24, 2026

NK Cell Infusion Shows Promise in Liver Cancer Trial

A Phase 2 trial of an off‑the‑shelf allogeneic NK‑cell infusion in patients with advanced hepatocellular carcinoma reported a 35% objective response rate and a disease‑control rate of 70%. The study, which enrolled 45 participants, showed median overall survival of 14.2 months,...

By Bioengineer.org
Barriers and Facilitators in Dementia Pain App Use
NewsJan 24, 2026

Barriers and Facilitators in Dementia Pain App Use

A recent study examined the adoption of a mobile app designed to assess pain in people with dementia, identifying both obstacles and enablers. Key barriers included cognitive limitations of users, low digital literacy among caregivers, and integration challenges with existing...

By Bioengineer.org
Smart Individuals Mature Early but Reproduce Slowly
NewsJan 24, 2026

Smart Individuals Mature Early but Reproduce Slowly

Researchers Yong and Kanazawa report that higher intelligence correlates with earlier puberty but slower reproductive timing. The study finds intelligent individuals tend to delay childbearing to prioritize education and career, resulting in lower fertility rates. Evolutionary analysis suggests a “quality‑over‑quantity”...

By Bioengineer.org
Transforming Blame to Learning: A Just Culture Impact
NewsJan 24, 2026

Transforming Blame to Learning: A Just Culture Impact

A just‑culture framework reframes workplace errors from blame to learning, encouraging transparent reporting and systematic analysis. Originating in high‑reliability sectors such as aviation and healthcare, the model is gaining traction across corporate environments. Companies adopting this mindset report measurable gains...

By Bioengineer.org
Glutamine Boosts NPDC1, Fueling Colorectal Cancer Progression
NewsJan 24, 2026

Glutamine Boosts NPDC1, Fueling Colorectal Cancer Progression

A recent study reveals that glutamine supplementation markedly increases the expression of NPDC1, a previously under‑appreciated oncogene, in colorectal cancer cells. Elevated NPDC1 drives cell proliferation, migration, and resistance to apoptosis, accelerating tumor progression in vitro and in mouse xenograft...

By Bioengineer.org
Implementing Science to Create Effective Wellness Hubs
NewsJan 24, 2026

Implementing Science to Create Effective Wellness Hubs

The article spotlights a new wave of science‑driven wellness hubs that synthesize recent research across multiple health domains. It references studies on youth alcohol‑abuse follow‑ups, culturally adapted health programs for Indigenous Mexicans, and subcutaneous pump advances for pulmonary arterial hypertension....

By Bioengineer.org
Future Directions in Pediatric Radiology AI Research
NewsJan 24, 2026

Future Directions in Pediatric Radiology AI Research

Future Directions in Pediatric Radiology AI Research outlines emerging priorities for applying artificial intelligence to child imaging. The article stresses the need for larger, annotated pediatric datasets, multimodal model integration, and explainable algorithms to gain clinician trust. It also highlights...

By Bioengineer.org
First-Movers Respond to Herding; BioMarin Vets Start New Biotech; GSK Buys RAPT Therapeutics; and More
NewsJan 24, 2026

First-Movers Respond to Herding; BioMarin Vets Start New Biotech; GSK Buys RAPT Therapeutics; and More

Industry leaders are reacting to a recent wave of investor herding by fast‑tracking biotech launches and strategic deals. BioMarin announced a new venture to spin out a next‑generation gene‑therapy platform, while GSK completed its acquisition of RAPT Therapeutics to bolster...

By Endpoints News
Unexpected Rituximab Reactions in Pemphigus Patients
NewsJan 24, 2026

Unexpected Rituximab Reactions in Pemphigus Patients

A recent multicenter study found that a notable subset of pemphigus patients receiving rituximab experienced unexpected severe infusion reactions, including cytokine release syndrome and anaphylaxis. The incidence was reported at roughly 12% of treated individuals, with most events occurring during...

By Bioengineer.org
Key Regulators of Ether Lipids in Adipocytes Revealed
NewsJan 24, 2026

Key Regulators of Ether Lipids in Adipocytes Revealed

A recent study published in Cell Metabolism has pinpointed the primary genetic and enzymatic regulators of ether lipid synthesis in adipocytes. Using CRISPR screens and lipidomics, researchers identified FAR1, AGPS, and the transcription factor PPARγ as central drivers. The work...

By Bioengineer.org
Characterizing WAK/WAKL Genes in Phaseolus Vulgaris
NewsJan 24, 2026

Characterizing WAK/WAKL Genes in Phaseolus Vulgaris

Researchers have completed a genome‑wide survey of wall‑associated kinase (WAK) and WAK‑like (WAKL) genes in Phaseolus vulgaris, the common bean. The study catalogued 30 members, mapped their chromosomal locations, and examined expression patterns across developmental stages and pathogen challenges. Phylogenetic...

By Bioengineer.org
Screening and Treating Hereditary Hemorrhagic Telangiectasia Early
NewsJan 24, 2026

Screening and Treating Hereditary Hemorrhagic Telangiectasia Early

Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic vascular disorder that can cause life‑threatening bleeding and arteriovenous malformations (AVMs). Recent clinical guidance emphasizes routine genetic testing and imaging for at‑risk individuals to catch lesions before symptoms appear. Early intervention—such as embolization...

By Bioengineer.org
AI-Powered Unified Framework for Automated Weed Detection
NewsJan 24, 2026

AI-Powered Unified Framework for Automated Weed Detection

A new AI‑powered unified framework for automated weed detection has been unveiled, combining multispectral imaging with advanced deep‑learning models. Early field trials across twelve major crops report a 94% detection accuracy and a 30% reduction in pesticide usage. The system...

By Bioengineer.org
Digitoxin Alters Follicular Development and Reproductive Health
NewsJan 24, 2026

Digitoxin Alters Follicular Development and Reproductive Health

Recent research by Jiang et al. demonstrates that digitoxin, a cardiac glycoside, triggers apoptosis in ovarian granulosa cells. The study connects this cell death to heightened oxidative stress and altered intracellular signaling pathways. Disrupted granulosa cell viability impairs follicular development, potentially...

By Bioengineer.org
Magnetostatic Pumping Enhances ECMO Efficiency Ex Vivo
NewsJan 24, 2026

Magnetostatic Pumping Enhances ECMO Efficiency Ex Vivo

A recent ex‑vivo study demonstrates that magnetostatic pumping can markedly improve extracorporeal membrane oxygenation (ECMO) efficiency. The novel pump design lowered circuit resistance and reduced blood trauma, achieving a 20‑30% increase in oxygen transfer while cutting hemolysis rates. Researchers reported...

By Bioengineer.org
Eco-Friendly Agrochemicals: Embracing Green Nanotechnology
NewsJan 24, 2026

Eco-Friendly Agrochemicals: Embracing Green Nanotechnology

The agrochemical sector is turning to green nanotechnology to create eco‑friendly pesticides and fertilizers. Researchers report that nano‑encapsulation can cut active ingredient use by up to 70% while maintaining pest control efficacy. Biodegradable nanomaterials ensure rapid breakdown, minimizing soil residues...

By Bioengineer.org
Coumarin-1,3,4-Oxadiazole Conjugates Target Alzheimer’s Disease
NewsJan 24, 2026

Coumarin-1,3,4-Oxadiazole Conjugates Target Alzheimer’s Disease

Researchers led by Arora have synthesized a new class of coumarin‑tethered 1,3,4‑oxadiazole conjugates that act as dual‑binding acetylcholinesterase inhibitors for Alzheimer’s disease. In vitro tests show several compounds surpass the potency of existing AChE drugs, while molecular docking confirms simultaneous...

By Bioengineer.org
Comparative Study of Mandarin Fish: Brain, Gut, Microbes
NewsJan 24, 2026

Comparative Study of Mandarin Fish: Brain, Gut, Microbes

Researchers published a multi‑omics study in BMC Genomics comparing brain transcriptomics, intestinal metabolomics and gut microbiome diversity in two mandarin fish groups that differed in body weight after artificial‑feed acclimation. Distinct gene‑expression patterns in the brain, divergent metabolite profiles in...

By Bioengineer.org
How Antigen Processing Shapes SARS-CoV-2 CD4+ T Cell Responses
NewsJan 24, 2026

How Antigen Processing Shapes SARS-CoV-2 CD4+ T Cell Responses

Recent immunological research reveals that the way viral proteins are processed inside antigen-presenting cells critically shapes the CD4+ T‑cell response to SARS‑CoV‑2. Specific proteolytic pathways generate a hierarchy of helper T‑cell epitopes, with the spike protein providing the most immunodominant...

By Bioengineer.org
Semaglutide’s Impact on Opioid Abstinence Explored
NewsJan 23, 2026

Semaglutide’s Impact on Opioid Abstinence Explored

Researchers have launched a randomized, double‑blind, placebo‑controlled trial to evaluate semaglutide, a GLP‑1 receptor agonist, for opioid use disorder treatment. The study will measure withdrawal symptoms, cravings, and abstinence among outpatient participants, aiming to determine whether semaglutide’s metabolic effects translate...

By Bioengineer.org
Streamlined Encoding for Medical 3D Printing Files
NewsJan 23, 2026

Streamlined Encoding for Medical 3D Printing Files

Researchers Zhao, Huang, and Xu introduced a lightweight encoding format that dramatically shrinks medical 3D‑printing files while preserving design fidelity. Their study demonstrates that the new format cuts data size, speeds downloads, and accelerates printer processing without compromising precision. Comparative...

By Bioengineer.org
Overcoming Barriers: Access to HIV and TB Care
NewsJan 23, 2026

Overcoming Barriers: Access to HIV and TB Care

The article highlights persistent barriers that limit access to HIV and TB care, including stigma, funding shortfalls, and fragmented health systems. It underscores how integrated service delivery, community health workers, and digital tools are closing gaps in diagnosis and treatment....

By Bioengineer.org
MicroRNA-15a/16-1 Deletion Boosts Stroke Recovery
NewsJan 23, 2026

MicroRNA-15a/16-1 Deletion Boosts Stroke Recovery

Researchers have demonstrated that genetic deletion of microRNA‑15a/16‑1 markedly accelerates functional recovery after experimental stroke. In mouse models, the knockout reduced infarct volume by roughly 30% and restored motor coordination within weeks. The therapeutic effect appears linked to heightened angiogenesis,...

By Bioengineer.org
Sex-Specific Molecular Divergence in Bladder Cancer Discovered
NewsJan 23, 2026

Sex-Specific Molecular Divergence in Bladder Cancer Discovered

Researchers have identified distinct molecular signatures in bladder cancer that differ by patient sex. Analyzing more than 1,200 tumor genomes and transcriptomes, the study found higher FGFR3 mutation rates in males and elevated immune checkpoint markers in females. These sex‑specific...

By Bioengineer.org
Brisk Demand for Follow-Ons Could Augur IPO Appetite: Public Equity Report
NewsJan 23, 2026

Brisk Demand for Follow-Ons Could Augur IPO Appetite: Public Equity Report

A quartet of public biotech companies announced enlarged follow‑on offerings, collectively raising $665 million. The upsized deals follow Aktis Oncology’s recent $365 million IPO, which expanded the Nasdaq biotech queue. Analysts interpret the strong demand for secondary offerings as a barometer of...

By BioCentury
IBD Linked to Colon Cancer Through TL1A-Driven Immune Pathway
NewsJan 23, 2026

IBD Linked to Colon Cancer Through TL1A-Driven Immune Pathway

Inflammatory bowel disease (IBD) heightens colorectal cancer risk through a TL1A‑driven immune pathway. TL1A activates gut‑resident ILC3 cells, prompting them to release GM‑CSF, which triggers emergency granulopoiesis and floods the colon with tumor‑promoting neutrophils. Mouse experiments showed that removing the...

By GEN (Genetic Engineering & Biotechnology News)
Factors Influencing Climate-Smart Farming in Nigeria
NewsJan 23, 2026

Factors Influencing Climate-Smart Farming in Nigeria

A recent study of Nigerian smallholder farmers identifies the primary drivers behind the uptake of climate‑smart agricultural practices. Access to reliable information, availability of financial resources, and robust social networks emerge as the most influential factors. Government policies and technology...

By Bioengineer.org
Novo's Wegovy Pill Off to a Solid Start After Just Two Weeks on Market
NewsJan 23, 2026

Novo's Wegovy Pill Off to a Solid Start After Just Two Weeks on Market

Novo Nordisk’s oral semaglutide, sold as the Wegovy pill, has demonstrated a strong start within its first three weeks on the U.S. market. Prescription volume has risen sharply, outpacing early forecasts and indicating robust demand for an oral alternative to...

By Endpoints News
Lung Cancer’s “Bodyguard System” Discovered by Singapore Scientists
NewsJan 23, 2026

Lung Cancer’s “Bodyguard System” Discovered by Singapore Scientists

Singapore’s A*STAR Institute of Molecular and Cell Biology identified a P2Y2‑integrin axis that protects mutant EGFR proteins in non‑small cell lung cancer from degradation. The study screened over 21,000 genes and found that excess extracellular ATP activates P2Y2, which partners...

By GEN (Genetic Engineering & Biotechnology News)
Macrophage-Targeting CAR T Cell Therapy Improves Survival in Solid Tumor Mouse Models
NewsJan 23, 2026

Macrophage-Targeting CAR T Cell Therapy Improves Survival in Solid Tumor Mouse Models

Scientists at Icahn School of Medicine have engineered IL-12‑producing CAR T cells that specifically target tumor‑associated macrophages (TAMs) rather than cancer cells. In mouse models of metastatic lung and ovarian cancer, the anti‑TAM CAR T therapy dramatically extended survival, with...

By GEN (Genetic Engineering & Biotechnology News)
EU Kicks Off One-Year Pilot to Expedite Multinational Trials
NewsJan 23, 2026

EU Kicks Off One-Year Pilot to Expedite Multinational Trials

The European Union has launched a one‑year voluntary pilot to accelerate the start of multinational clinical trials. The initiative introduces a single EU‑wide application that will be reviewed jointly by the European Medicines Agency and national regulators. By streamlining approval...

By Endpoints News
Ultra-Thin Wireless Retinal Implant Offers Hope for Safely Restoring Vision Signals
NewsJan 23, 2026

Ultra-Thin Wireless Retinal Implant Offers Hope for Safely Restoring Vision Signals

An international team led by Prof. Dr. Sedat Nizamoğlu at Koç University has created an ultra‑thin, wireless retinal implant that uses a photovoltaic nano‑assembly to convert near‑infrared light into precise electrical stimulation. The device operates at light intensities far below...

By Phys.org – Nanotechnology
With De-Risking the Mantra, Novartis Expands Presence in RNAi: Narasimhan in Conversation
NewsJan 23, 2026

With De-Risking the Mantra, Novartis Expands Presence in RNAi: Narasimhan in Conversation

Novartis CEO Vas Narasimhan says the company is de‑risking its platform bets by adding RNA interference (RNAi) to its portfolio. After early moves into radioligand therapies and autoimmune CAR‑T, Novartis has signed several RNAi licensing agreements and accelerated in‑house research. The...

By BioCentury
Assessing Inhibitory Control in Black-Tailed Gulls
NewsJan 23, 2026

Assessing Inhibitory Control in Black-Tailed Gulls

A recent study examined inhibitory control in black‑tailed gulls using detour‑reaching tasks across urban and coastal sites. The birds demonstrated a 70% success rate overall, with urban individuals outperforming their coastal peers. Repeated trials reduced latency, indicating learning and flexibility....

By Bioengineer.org
Diet Addresses Liver Dysfunction in Down Syndrome Mouse Model
NewsJan 23, 2026

Diet Addresses Liver Dysfunction in Down Syndrome Mouse Model

A study in Cell Reports shows that people with Down syndrome have markedly altered liver metabolism, including consistently higher bile acid levels in the bloodstream. Multi‑omic profiling of more than 400 participants and iPSC‑derived hepatocytes revealed intrinsic metabolic dysfunction and...

By GEN (Genetic Engineering & Biotechnology News)
F2G CEO Outlines Biotech's FDA Resubmission Plans, Funding and Expansion
NewsJan 23, 2026

F2G CEO Outlines Biotech's FDA Resubmission Plans, Funding and Expansion

F2G Biotherapeutics will re‑submit its lead antifungal candidate to the FDA after completing Phase 3 enrollment in June. The company has secured a new financing round to fund the filing and scale production. Expansion plans include a U.S. manufacturing site and...

By Endpoints News
Light-Controlled Switches Offer Precise Regulation of Ion Channels in Living Cells
NewsJan 23, 2026

Light-Controlled Switches Offer Precise Regulation of Ion Channels in Living Cells

Researchers at Leipzig University and TU Dresden have created two light‑responsive molecules, AzPico and AzHC, that act as reversible photoswitches for the TRPC4 and TRPC5 ion channels. The compounds activate the channels under violet light and inhibit them under blue...

By Phys.org – Biotechnology
Transitioning to Academic Dermatology: Key Motivators and Steps
NewsJan 23, 2026

Transitioning to Academic Dermatology: Key Motivators and Steps

The study by Jennings, Helm and Jackson investigates why late‑career dermatologists leave private practice for academia, focusing on financial, professional, and practical drivers. It shows that compensation often declines, but benefits such as research funding, job security and structured schedules...

By Bioengineer.org
New Route to Strychnos Alkaloids via Thiophene Cycloadditions
NewsJan 23, 2026

New Route to Strychnos Alkaloids via Thiophene Cycloadditions

Researchers have unveiled a novel synthetic route to Strychnos alkaloids that leverages thiophene cycloaddition chemistry. The method constructs the core indole‑pyridine framework in fewer steps and with higher overall yield than classical approaches. By employing readily available thiophene precursors, the...

By Bioengineer.org
StuffThatWorks Appoints Julie A. Ross as CEO and President
NewsJan 23, 2026

StuffThatWorks Appoints Julie A. Ross as CEO and President

StuffThatWorks announced Julie A. Ross, former CEO of Advanced Clinical, as its new CEO and President. Ross will steer the company’s growth of its patient‑derived AI platform that leverages a self‑perpetuating engine of over 3 million patients and 1.3 billion structured data...

By AI-TechPark
Teenage Pulmonary Artery Metrics via 3D MRI
NewsJan 23, 2026

Teenage Pulmonary Artery Metrics via 3D MRI

A new multi‑center study used three‑dimensional magnetic resonance imaging to map pulmonary artery dimensions in adolescents aged 12‑18. The research produced high‑resolution, non‑invasive measurements and established age‑ and sex‑specific reference ranges for artery diameter, cross‑sectional area, and curvature. Findings suggest...

By Bioengineer.org
Comparing Buprenorphine Forms in Jail Study
NewsJan 23, 2026

Comparing Buprenorphine Forms in Jail Study

A new correctional‑facility study evaluated sublingual tablets versus extended‑release injectable buprenorphine for treating opioid use disorder among incarcerated individuals. Researchers tracked medication adherence, post‑release overdose rates, and program costs over a 12‑month period. The injectable formulation showed higher retention and...

By Bioengineer.org
Rare Disease Vouchers Caught in Political Abyss. It Didn’t Have To Be This Way
NewsJan 23, 2026

Rare Disease Vouchers Caught in Political Abyss. It Didn’t Have To Be This Way

The Mikaela Naylon Give Kids a Chance Act, which would re‑authorize the rare pediatric disease priority‑review voucher (PRV) program, is stuck in a $1.2 trillion appropriations bill, jeopardizing its passage despite bipartisan support. The PRV program, created in 2012, grants vouchers...

By BioSpace
FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use
NewsJan 23, 2026

FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use

The FDA has issued a draft of M4Q(R2), a globally harmonized framework that structures quality information for pharmaceutical registration applications. The guidance splits data into Module 2.3 (quality overview) and Module 3 (body of data) and introduces the DMCS model to standardize...

By Pharmaceutical Technology
Real‐Time In Vivo Detection of Nanocarrier Number and Velocity in the Cerebrovasculature Using Hot Band Absorption
NewsJan 23, 2026

Real‐Time In Vivo Detection of Nanocarrier Number and Velocity in the Cerebrovasculature Using Hot Band Absorption

The study introduces DNA‑stabilized silver nanoclusters (DNA640) that emit anti‑Stokes fluorescence via hot‑band absorption, encapsulated in cationic mesoporous silica nanoparticles and coated with liposomes for enhanced brightness and chloride resistance. Using adeno‑associated virus‑driven albumin‑mNeonGreen to label mouse cerebrovasculature, researchers combined...

By Small (Wiley)